LGM
Logos Global Management’s Dyne Therapeutics DYN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.1M | Buy |
1,900,000
+1,400,000
| +280% | +$13.3M | 2% | 15 |
|
|
2025
Q1 | $5.23M | Buy |
500,000
+50,000
| +11% | +$523K | 0.93% | 25 |
|
|
2024
Q4 | $10.6M | Buy |
450,000
+290,000
| +181% | +$6.83M | 1.24% | 29 |
|
|
2024
Q3 | $5.75M | Sell |
160,000
-105,000
| -40% | -$3.77M | 0.62% | 36 |
|
|
2024
Q2 | $9.35M | Sell |
265,000
-1,465,000
| -85% | -$51.7M | 0.75% | 31 |
|
|
2024
Q1 | $49.1M | Sell |
1,730,000
-150,000
| -8% | -$4.26M | 3.98% | 7 |
|
|
2023
Q4 | $25M | Sell |
1,880,000
-300,000
| -14% | -$3.99M | 2.33% | 13 |
|
|
2023
Q3 | $19.5M | Buy |
2,180,000
+400,000
| +22% | +$3.58M | 2.61% | 12 |
|
|
2023
Q2 | $20M | Buy |
1,780,000
+80,000
| +5% | +$900K | 2.72% | 14 |
|
|
2023
Q1 | $19.6M | Sell |
1,700,000
-450,000
| -21% | -$5.18M | 2.8% | 13 |
|
|
2022
Q4 | $24.9M | Sell |
2,150,000
-137,321
| -6% | -$1.59M | 2.92% | 15 |
|
|
2022
Q3 | $29M | Sell |
2,287,321
-612,679
| -21% | -$7.78M | 3.57% | 11 |
|
|
2022
Q2 | $19.9M | Buy |
2,900,000
+165,608
| +6% | +$1.14M | 3.66% | 12 |
|
|
2022
Q1 | $26.4M | Sell |
2,734,392
-500,000
| -15% | -$4.82M | 3.42% | 16 |
|
|
2021
Q4 | $38.5M | Sell |
3,234,392
-385,000
| -11% | -$4.58M | 3.97% | 8 |
|
|
2021
Q3 | $58.8M | Buy |
3,619,392
+1,565,000
| +76% | +$25.4M | 4.24% | 5 |
|
|
2021
Q2 | $43.2M | Sell |
2,054,392
-1,150,000
| -36% | -$24.2M | 3.63% | 5 |
|
|
2021
Q1 | $49.8M | Buy |
3,204,392
+1,600,000
| +100% | +$24.8M | 4.86% | 4 |
|
|
2020
Q4 | $33.7M | Hold |
1,604,392
| – | – | 2.89% | 6 |
|
|
2020
Q3 | $32.4M | Buy |
+1,604,392
| New | +$32.4M | 4.15% | 8 |
|